Swiss pharma companies beat expecations
October 28, 2003Switzerland's number one pharmaceutical company Novartis has reported a sharp rise in sales in the first nine months of the …
Atypical anti-psychotics to get diabetes warning in US
October 28, 2003All atypical anti-psychotic drugs are to carry warnings on their US labels about potentially fatal hyperglycaemia side-effects and increased risk …
Job cuts at Merck
October 28, 2003US pharma giant Merck is to make 4,400 redundancies in an effort to stem falling profits, following a 7% drop …
Novartis Cox-II contender approved in UK
October 28, 2003A new rival to blockbuster Cox-II inhibitor drugs from Pfizer and Merck Sharp & Dohme has been approved in the …
Restructure unveiled as Pfizer takes merger hit
October 28, 2003Pfizer has unveiled a restructuring of its business to maximise its R&D and marketing might following the acquisition of Pharmacia …
New company to capitalise on industry M&A activity
October 28, 2003A new private European pharma company has been launched that will exploit products made available through the spate of industry …
AstraZeneca targets Canadian parallel imports
October 28, 2003AstraZeneca has become the second major pharma company to limit sales of drugs to Canada in a bid to curb …
New guidelines for industry ‘disease awareness’ campaigns
October 28, 2003Pharmaceutical industry 'disease awareness campaigns' aimed at UK consumers are to be governed by new guidelines to formalise the practice …
New guidance for nurse and GP specialists
October 28, 2003New guidance has been issued to help nurses and GPs take on extra roles that will expand primary care services.The …
Scientists race to identify and treat SARS
October 28, 2003Pharmaceutical companies, researchers and academic virologists around the world have joined the race to identify and ultimately develop vaccines to …
Income guarantee to salvage new GP contract
October 28, 2003Plans to offer GP practices a guaranteed minimum income have been launched to rescue the new general practice contract.The proposals …
$180bn Pfizer moves into a league of its own
October 28, 2003$180bn Pfizer moves into a league of its ownThe newly enlarged Pfizer has begun life bullishly with a 10% growth …
Companies pay $344m fraud settlement
October 28, 2003GlaxoSmithKline and Bayer have agreed to pay $344 million to settle charges of defrauding the US Government healthcare system.The payout …
Health service to pilot US system to tackle admissions
October 28, 2003Primary care trusts in England are to work with US healthcare provider Kaiser Permanente on new ways to reduce hospital …
Abbott looks to seize lion’s share of RA market with Humira
October 28, 2003Abbott Laboratories has launched its new rheumatoid arthritis treatment Humira in Europe claiming its biggest ever product could eventually become …
Latest content
FibroFind appoints Lee Borthwick as CEO
